Leukemia Clinical Trials

1685 clinical trials for Leukemia across international registries, including 108 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Natural History Study of Early Life Exposures in Agriculture (ELEA) — RECRUITING
• DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics — RECRUITING · NA
• MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2 — RECRUITING · NA
• Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy — RECRUITING
• RAT-HEMATO : Return to Work After Malignant Hemopathy — RECRUITING · NA
• A Study in Leukemia Patients With Karonudib — RECRUITING · PHASE1
• Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy — RECRUITING · PHASE2
• GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial — RECRUITING
• Mosaic Trial for Stem Cell Transplant Recipients — RECRUITING · NA
• Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL) — RECRUITING · NA
• Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia — RECRUITING · PHASE2
• Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant — RECRUITING · NA
• CIML NK Cells With Venetoclax for AML — RECRUITING · PHASE1
• Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing — RECRUITING
• Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors — RECRUITING · PHASE1
• Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases — RECRUITING · PHASE1
• Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) — RECRUITING · NA
• Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens — RECRUITING
• Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) — RECRUITING · PHASE2
• Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial — RECRUITING · PHASE2
• Pre-malignant States to Hematologic Malignancies in Firefighters — RECRUITING
• Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies — RECRUITING · PHASE1
• Halt Aging in Survivors of Blood Cancers — RECRUITING · NA
• Integrated Cancer Repository for Cancer Research — RECRUITING
• Registry of Older Patients With Cancer — RECRUITING
• A Study of Revumenib and Mezigdomide in People With Leukemia — RECRUITING · PHASE1
• Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission — RECRUITING · PHASE2
• Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation — RECRUITING · PHASE1
• Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) — RECRUITING
• Exercise as an Immune Adjuvant for Allogeneic Cell Therapies — RECRUITING · PHASE1
• Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors — RECRUITING
• Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution — RECRUITING
• Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant — RECRUITING
• A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties — RECRUITING · NA
• Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing — RECRUITING · NA
• Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies — RECRUITING
• Cohort of Patients With Chronic Myelomonocytic Leukemia — RECRUITING
• HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant — RECRUITING · PHASE1
• Cord Blood Transplantation in Children and Young Adults With Blood Cancer — RECRUITING · PHASE2
• MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing — RECRUITING · NA
• The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease — RECRUITING · NA
• Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT) — RECRUITING · PHASE2
• Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes — RECRUITING
• A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic Leukemia — RECRUITING · PHASE1
• Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy — RECRUITING · NA
• Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT — RECRUITING · PHASE1
• Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies — RECRUITING · PHASE1
• Revumenib in Combination With 7+3 + Midostaurin in AML — RECRUITING · PHASE1
• Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia — RECRUITING · PHASE1

Refine this search